Bank of New York Mellon Corp - CUMBERLAND PHARMACEUTICALS I ownership

CUMBERLAND PHARMACEUTICALS I's ticker is CPIX and the CUSIP is 230770109. A total of 45 filers reported holding CUMBERLAND PHARMACEUTICALS I in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of CUMBERLAND PHARMACEUTICALS I
ValueSharesWeighting
Q2 2024$115,160
-8.9%
75,2680.0%0.00%
Q1 2024$126,450
-6.2%
75,2680.0%0.00%
Q4 2023$134,858
-5.2%
75,2680.0%0.00%
Q3 2023$142,256
+154.0%
75,268
+279.3%
0.00%
Q1 2022$56,000
-39.8%
19,8430.0%0.00%
Q4 2021$93,000
+75.5%
19,8430.0%0.00%
Q3 2021$53,000
-5.4%
19,8430.0%0.00%
Q2 2021$56,000
-6.7%
19,8430.0%0.00%
Q1 2021$60,0000.0%19,843
-1.8%
0.00%
Q4 2020$60,000
-7.7%
20,2140.0%0.00%
Q3 2020$65,000
-3.0%
20,2140.0%0.00%
Q2 2020$67,000
-9.5%
20,2140.0%0.00%
Q1 2020$74,000
-28.8%
20,2140.0%0.00%
Q4 2019$104,000
-13.3%
20,2140.0%0.00%
Q3 2019$120,000
-6.2%
20,2140.0%0.00%
Q2 2019$128,000
+8.5%
20,2140.0%0.00%
Q1 2019$118,000
-4.1%
20,214
-0.6%
0.00%
Q4 2018$123,000
+6.0%
20,3380.0%0.00%
Q3 2018$116,000
-7.2%
20,3380.0%0.00%
Q2 2018$125,000
-24.7%
20,338
-18.1%
0.00%
Q1 2018$166,000
+10.7%
24,838
+22.1%
0.00%
Q4 2017$150,000
+4.9%
20,3380.0%0.00%
Q3 2017$143,000
+0.7%
20,3380.0%0.00%
Q2 2017$142,000
+0.7%
20,3380.0%0.00%
Q1 2017$141,000
+25.9%
20,3380.0%0.00%
Q4 2016$112,000
+8.7%
20,338
-1.3%
0.00%
Q3 2016$103,000
+7.3%
20,596
-3.5%
0.00%
Q2 2016$96,0000.0%21,3340.0%0.00%
Q1 2016$96,000
-14.3%
21,3340.0%0.00%
Q4 2015$112,000
-8.9%
21,334
-0.1%
0.00%
Q3 2015$123,000
-19.6%
21,359
+0.1%
0.00%
Q2 2015$153,000
+26.4%
21,334
+17.8%
0.00%
Q1 2015$121,000
+22.2%
18,118
+8.9%
0.00%
Q4 2014$99,000
+22.2%
16,643
+1.8%
0.00%
Q3 2014$81,000
-44.5%
16,343
-50.0%
0.00%
Q2 2014$146,000
+102.8%
32,686
+103.1%
0.00%
Q1 2014$72,000
-13.3%
16,0940.0%0.00%
Q4 2013$83,000
-47.5%
16,094
-53.8%
0.00%
Q3 2013$158,000
+90.4%
34,838
+116.5%
0.00%
Q2 2013$83,00016,0940.00%
Other shareholders
CUMBERLAND PHARMACEUTICALS I shareholders Q4 2013
NameSharesValueWeighting ↓
BARD ASSOCIATES INC 78,625$414,0000.24%
THOMPSON DAVIS & CO., INC. 16,650$88,0000.12%
Ariel Investments 1,416,660$7,452,0000.09%
Stanley-Laman Group, Ltd. 80,335$423,0000.07%
Spark Investment Management LLC 50,900$267,0000.03%
JW Asset Management, LLC 10,939$58,0000.02%
PDT Partners, LLC 25,634$135,0000.02%
EAGLE GLOBAL ADVISORS LLC 76,896$404,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 127,300$670,0000.01%
DELTA ASSET MANAGEMENT LLC/TN 12,000$63,0000.01%
View complete list of CUMBERLAND PHARMACEUTICALS I shareholders